McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 18, 2013 Market Watch article entitled, “Supreme Court satisfies few with ruling on generic drug settlements.” It seems the justices left no one content when it came to striking down a pact between a drug inventor and the maker of a generic form of that treatment on June 17, 2013. In other words, when it came down to ruling on a settlement between a former incarnation of AbbVie Inc. and Actavis Inc., the high court left very little settled. View the article